Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 514

1.

Emergency Contraception.

Upadhya KK; COMMITTEE ON ADOLESCENCE.

Pediatrics. 2019 Nov 18. pii: e20193149. doi: 10.1542/peds.2019-3149. [Epub ahead of print]

PMID:
31740497
2.

Mechanisms involved in the contraceptive effects of ulipristal acetate.

Munuce MJ, Gómez-Elías MD, Caille A, Bahamondes L, Cuasnicú PS, Cohen D.

Reproduction. 2019 Nov 1. pii: REP-19-0355.R2. doi: 10.1530/REP-19-0355. [Epub ahead of print] Review.

PMID:
31689233
3.

Differences in fibroid vascularity after three months of pre-treatment with leuprolide acetate or ulipristal acetate: A pilot study.

Frijlingh M, De Milliano I, Hehenkamp WJK, Huirne JAF.

Eur J Obstet Gynecol Reprod Biol. 2019 Aug 23. pii: S0301-2115(19)30370-7. doi: 10.1016/j.ejogrb.2019.08.002. [Epub ahead of print]

PMID:
31679806
4.

The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid Receptor.

Small B, Millard CEF, Kisanga EP, Burman A, Anam A, Flannery C, Al-Hendy A, Whirledge S.

J Clin Endocrinol Metab. 2019 Oct 29. pii: dgz139. doi: 10.1210/clinem/dgz139. [Epub ahead of print]

PMID:
31665442
5.

Liver function, tolerability and satisfaction during treatment with ulipristal acetate in women with fibroids: a single center experience.

Del Forno S, Degli Esposti E, Salucci P, Leonardi D, Iodice R, Arena A, Raimondo D, Paradisi R, Seracchioli R.

Gynecol Endocrinol. 2019 Oct 24:1-3. doi: 10.1080/09513590.2019.1680626. [Epub ahead of print]

PMID:
31646908
6.

Laparoscopic myomectomy after or without pre-treatment with ulipristal acetate.

Mara M, Boudova B, Lisa Z, Andrasova M, Dundr P, Kuzel D.

Minim Invasive Ther Allied Technol. 2019 Oct 16:1-8. doi: 10.1080/13645706.2019.1674337. [Epub ahead of print]

PMID:
31617772
7.

Predictors of uterine fibroid volume reduction under ulipristal acetate: a prospective MRI study.

Netter A, Pauly V, Siles P, Pivano A, Vidal V, Agostini A.

Reprod Biomed Online. 2019 Nov;39(5):795-801. doi: 10.1016/j.rbmo.2019.07.028. Epub 2019 Jul 17.

PMID:
31594689
8.

Trends in dispensing oral emergency contraceptives and safety issues: a survey of German community pharmacists.

Said A, Ganso M, Freudewald L, Schulz M.

Int J Clin Pharm. 2019 Sep 28. doi: 10.1007/s11096-019-00911-6. [Epub ahead of print]

PMID:
31564041
9.

In vitro effect of ulipristal acetate on human sperm parameters and function.

Sha W, Chang X, Han Y, Miao H, Yang Y.

Pak J Pharm Sci. 2019 May;32(3 Special):1419-1422.

PMID:
31551224
10.

Effect on surgical decisions: Ulipristal acetate as key player in Belgian phase IV registration trial.

Verguts J, Godin PA, De Vree B, Donnez O, Cosyns S, Luyckx M, Nisolle M.

Int J Gynaecol Obstet. 2019 Dec;147(3):339-343. doi: 10.1002/ijgo.12968. Epub 2019 Sep 30.

PMID:
31502668
11.

Ulipristal acetate vs gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Short-term results of a double-blind randomized controlled trial.

de Milliano I, Huirne JAF, Thurkow AL, Radder C, Bongers MY, van Vliet H, van de Lande J, van de Ven PM, Hehenkamp WJK.

Acta Obstet Gynecol Scand. 2019 Aug 29. doi: 10.1111/aogs.13713. [Epub ahead of print]

PMID:
31468503
12.

Psychometric validation of the 1-month recall Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire (UFS-QOL).

Coyne KS, Harrington A, Currie BM, Chen J, Gillard P, Spies JB.

J Patient Rep Outcomes. 2019 Aug 23;3(1):57. doi: 10.1186/s41687-019-0146-x.

13.

First Impressions Can Be Deceiving: Surgical Outcomes of Laparoscopic Myomectomy in Patients Pretreated with Ulipristal Acetate.

Frascà C, Arena A, Degli Esposti E, Raimondo D, Del Forno S, Moro E, Zanello M, Mabrouk M, Seracchioli R.

J Minim Invasive Gynecol. 2019 Aug 13. pii: S1553-4650(19)30373-5. doi: 10.1016/j.jmig.2019.04.026. [Epub ahead of print]

PMID:
31419494
14.

Ulipristal acetate in symptomatic uterine fibroids. A real-world experience in a multicentric Italian study.

Giarrè G, Franchini M, Castellacci E, Malune ME, Di Spiezio Sardo A, Saccone G, Angioni S.

Gynecol Endocrinol. 2019 Aug 8:1-4. doi: 10.1080/09513590.2019.1648419. [Epub ahead of print]

PMID:
31392917
15.

Emergency contraception and impact on abortion rates.

Michie L, Cameron ST.

Best Pract Res Clin Obstet Gynaecol. 2019 Jul 3. pii: S1521-6934(19)30087-2. doi: 10.1016/j.bpobgyn.2019.06.008. [Epub ahead of print] Review.

PMID:
31362908
16.

Availability of ulipristal acetate: A secret shopper survey of pharmacies in a metropolitan area on emergency contraception.

French VA, Mattingly TL, Rangel AV, Shelton AU.

J Am Pharm Assoc (2003). 2019 Nov - Dec;59(6):832-835. doi: 10.1016/j.japh.2019.06.018. Epub 2019 Jul 26.

PMID:
31358378
17.

Does ulipristal acetate emergency contraception (ella®) interfere with implantation?

Li HWR, Resche-Rigon M, Bagchi IC, Gemzell-Danielsson K, Glasier A.

Contraception. 2019 Jul 24. pii: S0010-7824(19)30368-3. doi: 10.1016/j.contraception.2019.07.140. [Epub ahead of print]

PMID:
31351035
18.

Ulipristal acetate on quality of life and sexual function of women with uterine fibromatosis.

Biscione A, Barra V, Bellone E, Severi FM, Luisi S.

Gynecol Endocrinol. 2019 Jul 22:1-6. doi: 10.1080/09513590.2019.1640202. [Epub ahead of print]

PMID:
31328597
19.

"My BMI is too high for Plan B." A changing population of women seeking ulipristal acetate emergency contraception online.

Cleland K, Wagner B, Smith NK, Trussell J.

Women Health. 2019 Jul 8:1-8. doi: 10.1080/03630242.2019.1635560. [Epub ahead of print]

PMID:
31284850
20.

Ulipristal versus Levonorgestrel for Emergency Contraception: A Review of Comparative Cost-Effectiveness [Internet].

Tran K, Grobelna A.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Feb 12.

Supplemental Content

Loading ...
Support Center